Literature DB >> 8553857

Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.

J D Sandy1, A H Plaas, T J Koob.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8553857

Source DB:  PubMed          Journal:  Acta Orthop Scand Suppl        ISSN： 0300-8827


× No keyword cloud information.
  12 in total

1.  Catabolism of aggrecan, decorin and biglycan in tendon.

Authors:  S G Rees; C R Flannery; C B Little; C E Hughes; B Caterson; C M Dent
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.

Authors:  M L Lemons; J D Sandy; D K Anderson; D R Howland
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

3.  Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.

Authors:  Hidefumi Oshita; John D Sandy; Kiichi Suzuki; Atsushi Akaike; Yun Bai; Tomohiro Sasaki; Katsuji Shimizu
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

4.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Immortalized, cloned mouse chondrocytic cells (MC615) produce three different matrix proteoglycans with core-protein-specific chondroitin/dermatan sulphate structures.

Authors:  R Kokenyesi; J E Silbert
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.

Authors:  J D Sandy; V Thompson; K Doege; C Verscharen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  [Histopathological degeneration score of fibrous cartilage. Low- and high-grade meniscal degeneration].

Authors:  V Krenn; B Kurz; M G Krukemeyer; P Knoess; M Jakobs; C Poremba; G Möllenhoff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

8.  [Meniscal degeneration score and NITEGE expression : immunohistochemical detection of NITEGE in advanced meniscal degeneration].

Authors:  V Krenn; P Knöss; W Rüther; M Jakobs; M Otto; M G Krukemeyer; A Heine; G Möllenhoff; B Kurz
Journal:  Orthopade       Date:  2010-05       Impact factor: 1.087

9.  Chondrocytes and meniscal fibrochondrocytes differentially process aggrecan during de novo extracellular matrix assembly.

Authors:  Christopher G Wilson; James F Nishimuta; Marc E Levenston
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

10.  Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.

Authors:  J D Sandy; D Gamett; V Thompson; C Verscharen
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.